Asset Management
Compare Stocks
2 / 10Stock Comparison
CNS vs HNNA
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
CNS vs HNNA — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Asset Management | Asset Management |
| Market Cap | $3.63B | $81M |
| Revenue (TTM) | $517M | $36M |
| Net Income (TTM) | $164M | $8M |
| Gross Margin | 46.8% | 70.1% |
| Operating Margin | 33.4% | 37.0% |
| Forward P/E | 20.8x | 8.0x |
| Total Debt | $141M | $41M |
| Cash & Equiv. | $183M | $72M |
CNS vs HNNA — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Cohen & Steers, Inc. (CNS) | 100 | 111.9 | +11.9% |
| Hennessy Advisors, … (HNNA) | 100 | 127.5 | +27.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CNS vs HNNA
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CNS is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 154.3% 10Y total return vs HNNA's -35.0%
- Lower volatility, beta 0.98, Low D/E 24.5%, current ratio 25.39x
- NIM 2.4% vs HNNA's 1.7%
HNNA carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.30, yield 5.3%
- Rev growth 19.9%, EPS growth 38.0%
- PEG 2.18 vs CNS's 16.52
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 19.9% NII/revenue growth vs CNS's 5.7% | |
| Value | Lower P/E (8.0x vs 20.8x), PEG 2.18 vs 16.52 | |
| Quality / Margins | Efficiency ratio 0.1% vs HNNA's 0.3% (lower = leaner) | |
| Stability / Safety | Beta 0.30 vs CNS's 0.98 | |
| Dividends | 5.3% yield, 1-year raise streak, vs CNS's 3.3% | |
| Momentum (1Y) | +1.2% vs CNS's -5.2% | |
| Efficiency (ROA) | Efficiency ratio 0.1% vs HNNA's 0.3% |
CNS vs HNNA — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CNS vs HNNA — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
HNNA leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
CNS is the larger business by revenue, generating $517M annually — 14.6x HNNA's $36M. Profitability is closely matched — net margins range from 29.2% (CNS) to 28.0% (HNNA).
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $517M | $36M |
| EBITDAEarnings before interest/tax | $198M | $11M |
| Net IncomeAfter-tax profit | $164M | $8M |
| Free Cash FlowCash after capex | -$94M | $10M |
| Gross MarginGross profit ÷ Revenue | +46.8% | +70.1% |
| Operating MarginEBIT ÷ Revenue | +33.4% | +37.0% |
| Net MarginNet income ÷ Revenue | +29.2% | +28.0% |
| FCF MarginFCF ÷ Revenue | +16.4% | +37.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +5.2% | -27.3% |
Valuation Metrics
HNNA leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 8.0x trailing earnings, HNNA trades at a 66% valuation discount to CNS's 23.9x P/E. Adjusting for growth (PEG ratio), HNNA offers better value at 2.18x vs CNS's 19.03x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $3.6B | $81M |
| Enterprise ValueMkt cap + debt − cash | $3.6B | $49M |
| Trailing P/EPrice ÷ TTM EPS | 23.94x | 8.03x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.79x | — |
| PEG RatioP/E ÷ EPS growth rate | 19.03x | 2.18x |
| EV / EBITDAEnterprise value multiple | 19.48x | 3.62x |
| Price / SalesMarket cap ÷ Revenue | 7.01x | 2.27x |
| Price / BookPrice ÷ Book value/share | 6.30x | 0.82x |
| Price / FCFMarket cap ÷ FCF | 42.64x | 6.03x |
Profitability & Efficiency
CNS leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
CNS delivers a 28.3% return on equity — every $100 of shareholder capital generates $28 in annual profit, vs $9 for HNNA. CNS carries lower financial leverage with a 0.25x debt-to-equity ratio, signaling a more conservative balance sheet compared to HNNA's 0.41x. On the Piotroski fundamental quality scale (0–9), HNNA scores 7/9 vs CNS's 5/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +28.3% | +8.5% |
| ROA (TTM)Return on assets | +20.5% | +5.3% |
| ROICReturn on invested capital | +19.2% | +7.3% |
| ROCEReturn on capital employed | +22.8% | +8.7% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.25x | 0.41x |
| Net DebtTotal debt minus cash | -$42M | -$32M |
| Cash & Equiv.Liquid assets | $183M | $72M |
| Total DebtShort + long-term debt | $141M | $41M |
| Interest CoverageEBIT ÷ Interest expense | — | 9.62x |
Total Returns (Dividends Reinvested)
HNNA leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HNNA five years ago would be worth $13,761 today (with dividends reinvested), compared to $11,824 for CNS. Over the past 12 months, HNNA leads with a +1.2% total return vs CNS's -5.2%. The 3-year compound annual growth rate (CAGR) favors HNNA at 18.6% vs CNS's 13.0% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +12.9% | +7.4% |
| 1-Year ReturnPast 12 months | -5.2% | +1.2% |
| 3-Year ReturnCumulative with dividends | +44.3% | +66.8% |
| 5-Year ReturnCumulative with dividends | +18.2% | +37.6% |
| 10-Year ReturnCumulative with dividends | +154.3% | -35.0% |
| CAGR (3Y)Annualised 3-year return | +13.0% | +18.6% |
Risk & Volatility
Evenly matched — CNS and HNNA each lead in 1 of 2 comparable metrics.
Risk & Volatility
HNNA is the less volatile stock with a 0.30 beta — it tends to amplify market swings less than CNS's 0.98 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CNS currently trades 84.7% from its 52-week high vs HNNA's 77.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.98x | 0.30x |
| 52-Week HighHighest price in past year | $83.99 | $13.19 |
| 52-Week LowLowest price in past year | $58.39 | $8.90 |
| % of 52W HighCurrent price vs 52-week peak | +84.7% | +77.3% |
| RSI (14)Momentum oscillator 0–100 | 63.1 | 51.6 |
| Avg Volume (50D)Average daily shares traded | 323K | 9K |
Analyst Outlook
Evenly matched — CNS and HNNA each lead in 1 of 2 comparable metrics.
Analyst Outlook
For income investors, HNNA offers the higher dividend yield at 5.26% vs CNS's 3.29%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Sell | — |
| Price TargetConsensus 12-month target | $76.00 | — |
| # AnalystsCovering analysts | 13 | — |
| Dividend YieldAnnual dividend ÷ price | +3.3% | +5.3% |
| Dividend StreakConsecutive years of raises | 2 | 1 |
| Dividend / ShareAnnual DPS | $2.34 | $0.54 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.6% | +0.6% |
HNNA leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). CNS leads in 1 (Profitability & Efficiency). 2 tied.
CNS vs HNNA: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is CNS or HNNA a better buy right now?
For growth investors, Hennessy Advisors, Inc.
(HNNA) is the stronger pick with 19. 9% revenue growth year-over-year, versus 5. 7% for Cohen & Steers, Inc. (CNS). Hennessy Advisors, Inc. (HNNA) offers the better valuation at 8. 0x trailing P/E, making it the more compelling value choice. Analysts rate Cohen & Steers, Inc. (CNS) a "Sell" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CNS or HNNA?
On trailing P/E, Hennessy Advisors, Inc.
(HNNA) is the cheapest at 8. 0x versus Cohen & Steers, Inc. at 23. 9x.
03Which is the better long-term investment — CNS or HNNA?
Over the past 5 years, Hennessy Advisors, Inc.
(HNNA) delivered a total return of +37. 6%, compared to +18. 2% for Cohen & Steers, Inc. (CNS). Over 10 years, the gap is even starker: CNS returned +154. 3% versus HNNA's -35. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CNS or HNNA?
By beta (market sensitivity over 5 years), Hennessy Advisors, Inc.
(HNNA) is the lower-risk stock at 0. 30β versus Cohen & Steers, Inc. 's 0. 98β — meaning CNS is approximately 225% more volatile than HNNA relative to the S&P 500. On balance sheet safety, Cohen & Steers, Inc. (CNS) carries a lower debt/equity ratio of 25% versus 41% for Hennessy Advisors, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CNS or HNNA?
By revenue growth (latest reported year), Hennessy Advisors, Inc.
(HNNA) is pulling ahead at 19. 9% versus 5. 7% for Cohen & Steers, Inc. (CNS). On earnings-per-share growth, the picture is similar: Hennessy Advisors, Inc. grew EPS 38. 0% year-over-year, compared to 14. 2% for Cohen & Steers, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CNS or HNNA?
Cohen & Steers, Inc.
(CNS) is the more profitable company, earning 29. 2% net margin versus 28. 0% for Hennessy Advisors, Inc. — meaning it keeps 29. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HNNA leads at 37. 0% versus 33. 4% for CNS. At the gross margin level — before operating expenses — HNNA leads at 70. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Which pays a better dividend — CNS or HNNA?
All stocks in this comparison pay dividends.
Hennessy Advisors, Inc. (HNNA) offers the highest yield at 5. 3%, versus 3. 3% for Cohen & Steers, Inc. (CNS).
08Is CNS or HNNA better for a retirement portfolio?
For long-horizon retirement investors, Hennessy Advisors, Inc.
(HNNA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 30), 5. 3% yield). Both have compounded well over 10 years (HNNA: -35. 0%, CNS: +154. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between CNS and HNNA?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CNS is a small-cap income-oriented stock; HNNA is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.